Pr J.-D
It belongs to a novel class of drugs known as triple agonists, meaning it simultaneously activates three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Thats a meaningful result for patients with moderate weight loss goals, but its substantially less than what GLP-1 medications typically produce
This can be achieved by: Increasing weight/resistance Increasing repetitions at the same weight Increasing sets Reducing rest intervals (with caution to maintain form) For GLP-1 users who are losing weight and potentially losing some strength alongside fat, the priority is to maintain or slowly progress load rather than aggressively push weights
(source: prnewswire.com) February 2025: Novo Nordisk announced that the FDA officially declared the shortages of Wegovy and Ozempic resolved, confirming that supply in the U.S
How It Works Complete a 100% online intake form covering medical history and weight-loss goals A licensed provider will review your information and will decide whether to prescribe If approved, your prescription will be sent to Embodys state-licensed sterile compounding pharmacy You can expect the medication to arrive at your door in 1-2 days The patient portal continues to provide care and will provide updates on dose changes, coaching, and support Due to the fact that everything is online and there is no required video appointment, you can expect to receive the medication within 1-2 days